ClariVest Asset Management’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-8,610
Closed -$335K 752
2022
Q3
$335K Sell
8,610
-26
-0.3% -$1.19K 0.02% 402
2022
Q2
$333K Hold
8,636
0.01% 422
2022
Q1
$418K Buy
8,636
+3,011
+54% +$155K 0.02% 410
2021
Q4
$413K Sell
5,625
-27,858
-83% -$2.29M 0.01% 449
2021
Q3
$3.05M Sell
33,483
-3,101
-8% -$264K 0.1% 195
2021
Q2
$2.3M Buy
36,584
+36,521
+57,970% +$1.35M 0.08% 207
2021
Q1
$2K Hold
63
﹤0.01% 621
2020
Q4
$1K Buy
+63
New +$1.13K ﹤0.01% 739

Other funds holding ASTH

ClariVest Asset Management's ASTH Position: Q4 2022 in Review

ClariVest Asset Management sold out of Astrana Health (ASTH) in Q4 2022, closing a stake of 8,610 shares — an estimated $335K sold.

ClariVest Asset Management first reported a position in ASTH in Q4 2020 and held it in 8 quarters. The position peaked at $3.05M in Q3 2021. 130 funds tracked by Wall St. Rank hold ASTH as of Q4 2022.

  • ClariVest Asset Management reported no remaining Astrana Health position as of Q4 2022 after selling out during the quarter.
  • ClariVest Asset Management sold 8,610 Astrana Health shares in Q4 2022, an estimated $335K.
  • ClariVest Asset Management first reported a position in Astrana Health in Q4 2020 and held it in 8 quarters.
  • ClariVest Asset Management's Astrana Health position peaked at $3.05M in Q3 2021.
  • 130 funds tracked by Wall St. Rank held Astrana Health as of Q4 2022.

Based on ClariVest Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.